Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

25 févr. 2025 15h50 HE | Source: Portnoy Law

Revance Therapeutics, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. March 4, 2025 Deadline to file Lead Plaintiff Motion.

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Feb. 25, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Revance Therapeutics, Inc....
30 oct. 2024 09h30 HE | Source: KUEHN LAW, PLLC

Kuehn Law Encourages PFIE, GLYC, RVNC, and RCM Investors to Contact Law Firm

Kuehn Law Encourages PFIE, GLYC, RVNC, and RCM Investors to Contact Law Firm
18 oct. 2024 09h17 HE | Source: KUEHN LAW, PLLC

Kuehn Law Encourages ZUO, ARC, K, and RVNC Investors to Contact Law Firm

Kuehn Law Encourages ZUO, ARC, K, and RVNC Investors to Contact Law Firm
03 nov. 2021 11h21 HE | Source: Portnoy Law

Revance Therapeutics, Inc. Investors: Company Investigated by the Portnoy Law Firm

LOS ANGELES, Nov. 03, 2021 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Revance Therapeutics, Inc. ("Revance" or the "Company") (NASDAQ: RVNC) investors that the firm has initiated an...